Personal information

Emails & domains

Verified email addresses

Verified email domains

Countries

Peru

Activities

Collapse all

Education and qualifications (3)

Universitat de Barcelona: Barcelona, ES

2023-09-18 to 2024-07-24 | Master's Degree in Atomistic and Multiscale Computational Modelling in Physics, Chemistry and Biochemistry (Department of Physical Chemistry)
Qualification
Source: Self-asserted source
Margot Inés Paco Chipana

Universidad Católica de Santa María de Arequipa: Arequipa, Arequipa, PE

2014-03-10 to 2018-12-17 | Ingeniero Biotecnólogo (Arequipa)
Qualification
Source: Self-asserted source
Margot Inés Paco Chipana

Universidad Catolica de Santa María: Arequipa, Arequipa, PE

2014-03-10 to 2018-12-17 | Bachiller (Arequipa)
Education
Source: Self-asserted source
Margot Inés Paco Chipana

Works (7)

Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations

F1000Research
2024-11-22 | Journal article
DOI: 10.12688/f1000research.143633.3
Contributors: Haruna Luz Barazorda-Ccahuana; Eymi Gladys Cárcamo Rodriguez; Angela Emperatriz Centeno-Lopez; Margot Paco-Chipana; Luis Daniel Goyzueta-Mamani; Miguel Angel Chavez-Fumagalli
Source: check_circle
Crossref

In silico analysis of the action of saturated, monounsaturated, and polyunsaturated fatty acids against Echinococcus granulosus fatty-acid-binding protein 1

F1000Research
2024-11-21 | Journal article
DOI: 10.12688/f1000research.146070.2
Contributors: Margot Paco-Chipana; Karel Mena-Ulecia; Yoan Hidalgo Rosa; Maria Isabel Herrera Valdivida; Luis Daniel Goyzueta-Mamani; Berly Cardenas-Pillco; Miguel Angel Chavez-Fumagalli; Haruna Luz Barazorda-Ccahuana
Source: check_circle
Crossref

Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations

F1000Research
2024-10-29 | Journal article
DOI: 10.12688/f1000research.143633.2
Contributors: Haruna Luz Barazorda-Ccahuana; Eymi Gladys Cárcamo Rodriguez; Angela Emperatriz Centeno-Lopez; Margot Paco-Chipana; Luis Daniel Goyzueta-Mamani; Miguel Angel Chavez-Fumagalli
Source: check_circle
Crossref

Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents ThroughIn SilicoAnalysis AndIn VitroEfficacy

2024-10-04 | Preprint
DOI: 10.1101/2024.10.04.616659
Contributors: Luis Daniel Goyzueta-Mamani; Daniela Pagliara Lage; Haruna Luz Barazorda-Ccahuana; Margot Paco-Chipana; Mayron Antonio Candia-Puma; Gonzalo Davila-Del-Carpio; Alexsandro Sobreira Galdino; Ricardo Andrez Machado-de-Avila; Rodolfo Cordeiro Giunchetti; Edward L. D’Antonio et al.
Source: check_circle
Crossref

In silico analysis of the action of saturated, monounsaturated, and polyunsaturated fatty acids against Echinococcus granulosus fatty-acid-binding protein 1

F1000Research
2024-04-19 | Journal article
DOI: 10.12688/f1000research.146070.1
Contributors: Margot Paco-Chipana; Karel Mena-Ulecia; Yoan Hidalgo Rosa; Maria Isabel Herrera Valdivida; Luis Daniel Goyzueta-Mamani; Berly Cardenas-Pillco; Miguel Angel Chavez-Fumagalli; Haruna Luz Barazorda-Ccahuana
Source: check_circle
Crossref

Identification of compounds from natural Peruvian sources as potential inhibitors of SARS-CoV-2 Mpro mutations by virtual screening and computational simulations

F1000Research
2024-04-04 | Journal article
DOI: 10.12688/f1000research.143633.1
Contributors: Haruna Luz Barazorda-Ccahuana; Eymi Gladys Cárcamo Rodriguez; Angela Emperatriz Centeno-Lopez; Margot Paco-Chipana; Luis Daniel Goyzueta-Mamani; Miguel Angel Chavez-Fumagalli
Source: check_circle
Crossref

Novel In Silico Insights into Rv1417 and Rv2617c as Potential Protein Targets: The Importance of the Medium on the Structural Interactions with Exported Repetitive Protein (Erp) of Mycobacterium tuberculosis

Polymers
2022-06-25 | Journal article
DOI: 10.3390/polym14132577
Contributors: Margot Paco-Chipana; Camilo Febres-Molina; Jorge Alberto Aguilar-Pineda; Badhin Gómez
Source: check_circle
Crossref
grade
Preferred source (of 2)‎
How many people are using ORCID?